Valuation: Solara Active Pharma Sciences Limited

Market Cap 30.72B 323M 290M 268M 243M 454M 460M 3.21B 1.28B 16.1B 1.21B 1.19B 51.06B P/E 2025
3,792x
P/E 2026 -253x
Enterprise Value 37.51B 395M 354M 327M 297M 555M 561M 3.92B 1.56B 19.66B 1.48B 1.45B 62.35B EV / Sales 2025
2.54x
EV / Sales 2026 1.99x
Free-Float
47.77%
Yield 2025 *
-
Yield 2026 -
1 day+2.69%
1 week+0.86%
Current month-9.87%
1 month-11.20%
3 months+28.95%
6 months+36.74%
Current year+15.73%
1 week 592.8
Extreme 592.8
669
1 month 525.15
Extreme 525.15
767.9
Current year 422
Extreme 422
774
1 year 422
Extreme 422
774
3 years 286
Extreme 286
882.8
5 years 286
Extreme 286
1,384
10 years 134.5
Extreme 134.5
1,859.95
Manager TitleAgeSince
Chief Executive Officer - 21/02/2025
Director of Finance/CFO - 21/02/2025
Chief Tech/Sci/R&D Officer 74 10/08/2026
Director TitleAgeSince
Chairman 73 11/04/2018
Director/Board Member 58 11/04/2018
Director/Board Member 75 14/11/2023
Date Insider Type Main position Quantity % Market Cap. Importance
14/03/25 Buy

Director

1,000 0.0021%
06/03/25
Pronomz Ventures LLP
BuyCompany 13,600 0.0283%
04/03/25
Pronomz Ventures LLP
BuyCompany 216,361 0.4503%
Change 5-day change 1-year change 3-year change Capi.($)
+2.69%+0.86%+11.16%+111.21% 323M
+0.22%-0.14%+55.12%+128.82% 1,143B
+0.91%+3.61%+41.21%+84.57% 647B
-0.12%-0.93%+25.59%+106.14% 506B
-1.52%+0.31%+50.59%+62.95% 384B
+0.86%-4.37%+61.16%+37.93% 350B
-0.19%+1.36%+30.07%+51.96% 293B
-1.09%+0.75%+2.44%+24.38% 265B
+0.75%+2.05%+53.85%+71.25% 242B
+0.25%+1.64%+32.05%+107.62% 197B
Average -0.16%+0.62%+36.33%+78.68% 402.79B
Weighted average by Cap. -0.62%+0.71%+42.77%+87.72%

Financials

2025 2026
Net sales 12.84B 135M 121M 112M 102M 190M 192M 1.34B 533M 6.73B 507M 496M 21.34B 13.69B 144M 129M 119M 108M 202M 205M 1.43B 569M 7.18B 541M 529M 22.75B
Net income 5.4M 56.85K 51.02K 47.11K 42.72K 79.85K 80.83K 565K 224K 2.83M 213K 209K 8.98M -74.1M -780K -700K -646K -586K -1.1M -1.11M -7.75M -3.08M -38.84M -2.93M -2.87M -123M
Net Debt 7.92B 83.4M 74.85M 69.11M 62.67M 117M 119M 829M 329M 4.15B 313M 306M 13.17B 6.79B 71.49M 64.17M 59.25M 53.73M 100M 102M 710M 282M 3.56B 268M 263M 11.29B
Projected Income Statement - Annual - Solara Active Pharma Sciences Limited
Logo Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited is an India-based global, pureplay active pharmaceutical ingredients (API) company. The Company is engaged in the manufacturing and development of APIs and offers contract manufacturing and development services for global companies. Its commercial product category includes Albendazole, Aprepitant (Antiemetic), Colchicine, Citicoline Sodium, Disulfiram, Dolutegravir, Etomidate, Flucytosine, Ibuprofen Arginine, Lurasidone Hydrochloride, Rifaximin, Tioconazole, Zileuton and others. Its research and development (R&D) product category includes Brivaracetam, Flecainide Acetate, Naproxen Base, Obeticholic acid, Patiromer Sorbitex Calcium, Rotigotine, Safinamide, Sapropterin, Sugammadex, Tranexamic Acid, Sucroferric Oxyhydroxide and others. Its business is spread across 70 countries with operations in the key markets of North America, Europe, Japan, South Korea and the Middle East and North Africa. It has one R&D center in Chennai.
Employees
1,669
Date Price Change Volume
28/10/26 ₹653.80 +2.69% 218,304
27/10/26 ₹636.70 +0.34% 314,775
26/10/26 ₹634.55 +3.76% 242,609
23/10/26 ₹611.55 -1.21% 534,153
22/10/26 ₹619.05 -4.50% 456,451

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Solara Active Pharma Sciences Limited
  1. Stock Market
  2. Stocks
  3. SOLARA Stock